NANJING, China and GAITHERSBURG, Md., Aug. 7, 2026 /PRNewswire/ -- TransThera Sciences' Yochanra® is the first drug independently developed in China to address the longstanding global challenge of acquired resistance to FGFR inhibitor therapy in patients with cholangiocarcinoma. On 6...
Hence then, the article about yochanra the world s first innovative drug to overcome fgfr inhibitor resistance makes its global debut in china was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Yochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China )
Also on site :
- ‘KPop Demon Hunters’ Has Led Billboard’s Top Soundtracks Chart for 54 Weeks: Only One Soundtrack Has Led Longer (Full List)
- Katey Sagal Recalls Becoming 'A Mother Again at 52'
- This OK Go Music Video Broke the Internet in 2006—Nearly 20 Years Later, That Treadmill Routine Still Stops You in Your Tracks